International Biotechnology (LON:IBT – Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 688.63 and traded as high as GBX 904. International Biotechnology shares last traded at GBX 882.30, with a volume of 168,859 shares traded.
International Biotechnology Stock Down 2.8%
The stock has a market capitalization of £285.65 million, a P/E ratio of 18.25 and a beta of 0.21. The stock’s 50 day moving average price is GBX 809.12 and its 200-day moving average price is GBX 689.09.
International Biotechnology (LON:IBT – Get Free Report) last posted its earnings results on Thursday, November 6th. The company reported GBX (11.42) earnings per share for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. Analysts anticipate that International Biotechnology will post 0.9435943 earnings per share for the current year.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Read More
- Five stocks we like better than International Biotechnology
- Investing in Commodities: What Are They? How to Invest in Them
- Red Cups or Red Flags: Starbucks’ Bet on a Holiday Recovery
- Basic Materials Stocks Investing
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- How to Use the MarketBeat Dividend Calculator
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
